McKesson Contracts With Small Manufacturers Will Set Stage For Big Pharma Fee-For-Service Talks
This article was originally published in The Pink Sheet Daily
Executive Summary
The wholesaler is implementing core distribution agreements for its smaller “tier four” manufacturing partners effective June 1. McKesson says it is encouraged by initial response to the transition.
You may also be interested in...
McKesson Cites Rx Pricing Restraint In Earnings Warning
Number of price increases in current quarter is lowest in four years, McKesson says. Wholesaler expects to meet full year earnings targets – assuming that “majority” of expected price increases are realized.
McKesson Cites Rx Pricing Restraint In Earnings Warning
Number of price increases in current quarter is lowest in four years, McKesson says. Wholesaler expects to meet full year earnings targets – assuming that “majority” of expected price increases are realized.
McKesson's Manufacturer Contracts Set Payment Floor For Price Speculation
A "large portion" of the wholesaler's arrangements with manufacturers are still tied to price increases. Nevertheless, McKesson says it is making progress in transitioning to core distribution agreements, with most smaller brand manufacturers now paying fee-for-service.